ReviewCurrent psychiatry reports2026
Recurrent Deliberate Foreign Body Ingestion: Psychiatric Comorbidities, Management Strategies, and Ethical Considerations.
Review in Current psychiatry reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewRecurrent deliberate foreign body ingestion (DFBI) is a high-risk, resource-intensive behavior most often associated with underlying psychiatric conditions. Although medical and surgical complications are well documented, the psychiatric drivers and optimal management of DFBI are less well characterized. This review synthesizes current evidence on the epidemiology, psychiatric comorbidities, behavioral mechanisms, management strategies, and ethical challenges associated with DFBI [1, 2, 4, 6]. RECENT
findingsRecent work highlights the roles of emotion dysregulation, personality pathology-particularly borderline personality disorder-and reinforcement mechanisms in perpetuating recurrent ingestion [1, 3, 10]. A small subset of individuals accounts for a disproportionate share of hospitalizations, underscoring the chronic and relapsing nature of this behavior and its substantial healthcare costs [1, 4]. Effective care requires coordinated multidisciplinary management that integrates medical stabilization with psychiatric treatment, including structured behavioral plans, consistent team-based responses, and attention to countertransference [2, 7]. Psychotherapeutic modalities, particularly dialectical behavior therapy and borderline personality disorder-informed models, are central to long-term management, while pharmacologic interventions primarily target comorbid conditions rather than ingestion [10-12]. Ethical considerations, including assessment of decision-making capacity, perceptions of futility, and resource allocation, further complicate care [13-15]. DFBI is a complex, recurrent behavior driven by diverse psychiatric, behavioral, and systemic factors. Effective management requires coordinated multidisciplinary care that integrates medical stabilization, psychiatric treatment, structured behavioral interventions, and ethical decision-making to reduce recurrence and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.